ARTICLE | Clinical News
Extended release tramadol: CLC's Cipher Pharmaceuticals Inc. subsidiary submitted an IND to begin U.S. and Canadian Phase II testing of its once-daily tramadol
January 22, 2002 8:00 AM UTC
Canadian Medical Laboratories Ltd. (TSE:CLC), Mississauga, Ontario Product: Extended release tramadol Business: Neurological Therapeutic category: Analgesic, Neurotransmission Target: Opioid receptor...